Valganciclovir in Congenital CMV Infants
Public ClinicalTrials.gov record NCT00031434. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/II Pharmacokinetic and Pharmacodynamic Evaluation of Oral Valganciclovir in Neonates With Symptomatic Congenital Cytomegalovirus (CMV) Infection (CASG 109)
Study identification
- NCT ID
- NCT00031434
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 24 participants
Conditions and interventions
Conditions
Interventions
- Ganciclovir Drug
- Valganciclovir Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 30 Days
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2002
- Primary completion
- Jun 30, 2007
- Completion
- Jun 30, 2007
- Last update posted
- Feb 6, 2011
2002 – 2007
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| University of Arkansas | Little Rock | Arkansas | 72202-3591 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| Children's Hospital of Orange County | Orange | California | 92868 | — |
| Stanford University | Stanford | California | 94305 | — |
| University of Florida | Jacksonville | Florida | 32209 | — |
| Stroger Cook Hospital | Chicago | Illinois | 60612 | — |
| University of Louisville | Louisville | Kentucky | 40202-3830 | — |
| Tulane University | New Orleans | Louisiana | 70112 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Washington University in St. Louis | St Louis | Missouri | 63110 | — |
| Creighton University | Omaha | Nebraska | 68198-2162 | — |
| Schneider Children's Hospital | Manhasset | New York | 11030 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| MetroHealth Medical Center | Cleveland | Ohio | 44109-1998 | — |
| Ohio State University | Columbus | Ohio | 43205 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| The University of Texas Southwestern Medical Center | Dallas | Texas | 75390-9063 | — |
| Cook Children's Medical Center | Fort Worth | Texas | 76104 | — |
| The University of Texas Medical Branch | Galveston | Texas | 77555 | — |
| The University of Texas Health Science Center | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00031434, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2011 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00031434 live on ClinicalTrials.gov.